title: Cortical hyperexcitability in migraine patients before and after sodium valproate treatment.
abstract: DC-magnetoencephalography (DC-MEG)waveforms arising during migraine aura were used to determine the effectiveness of prophylactic medication therapy on neuronal hyperexcitability. Nine patients were prescribed valproate (Depakote) for migraine prophylaxis. MEG scans were recorded during visual stimulation before commencing medication and again after 30 days of daily use of valproate. Cortical brain activity was recorded during stimulation with a black-and-white circular checkerboard pattern alternating at 8 Hz and were analyzed with MR-FOCUSS. Large-amplitude DC-MEG signals, imaged to extended areas of occipital cortex, were seen before therapy. After 30 days of prophylactic treatment, reduced DC-MEG shifts in the occipital cortex and reduced incidence of migraine attacks were observed. Using visual stimulation, the authors demonstrated the hyperexcitability of widespread regions throughout occipital cortex in migraine patients, explaining the susceptibility for triggering spreading cortical depression and migraine aura. This study confirms that MEG can noninvasively determine the status of neuronal excitability before and after therapy. This finding may be helpful in determining which prophylactic medications will be most effective in reducing hyperexcitability in particular patients.
authors.affiliation: Henry Ford Health System, Detroit, Michigan, USA. drsusan@umich.edu
authors.forename: Susan M
authors.initials: SM
authors.lastname: Bowyer
authors.forename: Karen M
authors.initials: KM
authors.lastname: Mason
authors.forename: John E
authors.initials: JE
authors.lastname: Moran
authors.forename: Norman
authors.initials: N
authors.lastname: Tepley
authors.forename: Panayiotis D
authors.initials: PD
authors.lastname: Mitsias
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D001931:Brain Mapping; D005260:Female; D006801:Humans; D015225:Magnetoencephalography; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology*; D010775:Photic Stimulation / Q000379:methods; D014635:Valproic Acid / Q000627:therapeutic use*; D014793:Visual Cortex / Q000187:drug effects / Q000503:physiopathology*
chemical_list: D000927:Anticonvulsants; D014635:Valproic Acid